NCT04495790 · Advanced Integrative Medical Science Institute
AIMS Cancer Outcomes Study
(ACOS)
What this study is about
The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year how long patients live (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a forward-looking consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.
View original scientific description
The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.
Primary outcome measures
AIM 1 (survival)
Time frame: 5 Years
Measure DFS and OS in advanced stage cancer patients who receive AIO treatments at AIMS Institute.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- A new patient coming in for a first office call (FOC) or first consultation via telemedicine with a diagnosis of cancer, or
- An established patient with a diagnosis of cancer receiving treatment at the AIMS Institute;
- If over 18 years of age are able to understand study design adequately and provide signed informed consent (IC) to enrollment;
- If younger than 18 years of age informed assent from the child and informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient;
- A confirmed diagnosis of cancer based on medical oncology medical records.
Exclusion criteria
- Patients not diagnosed with cancer;
- Telehealth patients;
- Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
- Unwilling to participate in the AIMS Institute observational study.
Where
- Seattle, Washington
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Feb 1, 2023 · Source of record for eligibility and locations